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eptospirosis, caused by a number of 
species in the genus Leptospira, has a 
worldwide distribution and may have 
the greatest incidence of any zoonosis 1. 
Leptospires infect a variety of wild and 
domestic animals, which become 
reservoirs of disease when the 
organisms establish persistent infection 
in the animals' kidneys. The organism is 
excreted in the urine of infected animals, 
particularly rats and other rodents. 
Leptospires enter the body through cuts, 
abraded skin, or intact mucous 
membranes; aerosol inhalation; and  
possibly ingestion of contaminated food 
or water 2. Leptospirosis can occur 
among people exposed to animals, 
animal products or contaminated soil or 
L
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Leptospirosis is an acute generalized infectious disease, caused by spirochaetes, 
Leptospira interrogans. The severity of the disease ranges from an asymptomatic 
subclinical course to a fatal outcome. Pulmonary involvement is common but often 
mild and of little clinical significance. However, over the last two decades an 
increasing number of cases have been reported with pulmonary haemorrhage as a 
prominent feature. We describe here a case of leptospirosis who presented with 
cough and hemoptysis. The patient acquired the disease in Saudi Arabia. Even in the 
absence of any travel, the association of fever, hemoptysis, jaundice, and 
thrombocytopenia, should lead to the suspicion of leptospirosis. Clinical and 
epidemiological aspects of the disease are discussed in the article. 
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water. Veterinarians, farmers, abattoir workers, military personnel and sewer 
workers are at increased risk for 
occupational disease. The disease is 
increasingly diagnosed in travelers  3. Of 
importance to the traveler, recreational 
water exposures have been associated 
with individual cases and outbreaks of 
disease. Leptospirosis is a rare disease in 
Saudi Arabia. However its incidence is 
probably underestimated, due to its 
broad spectrum of presentations, 
including subclinical benign forms and 
the ictero-hemorragic form of the Weil's 
syndrome, whose mortality is high. We 
describe here a case of leptospirosis 
acquired in Saudi Arabia with a 
favourable outcome. Even in the 
absence of any travel, the association of 
jaundice, fever, lethargy, hemoptysis, 
thrombocytopenia, and renal 
abnormalities should lead to the 
suspicion of leptospirosis. Clinical and 
epidemiological aspects of the disease 
are discussed in the article. 
 
Case report 
A previously healthy 34-years 
Bangladeshi man presented with history 
of fever, muscle pain, and headache of 5 
days duration. He was  seen by a family 
doctor and Clavuloxin was prescribed 
for him with no improvement. One 
week later he started to have cough with 
hemoptysis. He had also nausea and 
vomiting and lost 2 kilogram of weight. 
He works as a plumper and his last visit 
to his country was two years before 
presentation. On admission he was pale 
and jaundiced, with a temperature of 
40Ő C. The liver was palpable with 14 cm 
span. Initial laboratory studies revealed 
anemia, thrombocytopenia and 
moderate liver impairment (Table 1). 
 
 Table 1. Laboratory results 
Test On Admission On Discharge 
WBCs(109/L) 3.2 6
HB (g/dl) 9.5 10.7
PLTs (X109/L) 65 254
Total bilirubin (mg/dl) 6.4 1.4
Direct bilirubin 4.2 0.8 
Aspartate transaminase (AST) 210 55
Alanine transminase (ALT) 199 43
Alkaline phosphatase 419 195
BUN mg/dl 22 19
Creatinine mg/dl 1.2 0.9 
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His chest radiograph demonstrated 
atelectatic band at the right lower lung 
lobe with minimal pleural collection 
seen bilaterally. He was started on 
ceftriaxone for a presumed pneumonia. 
The following day, he continued to have 
multiple episodes of hemoptysis (< 100 
ml total). Acid fast stain and malaria 
smears were negative repeatedly. 
Serology was sent for legionella, 
leptospirosis and Q fever. His hepatic 
serology was negative and blood, urine 
and sputum cultures showed no 
growth. Initial urine analysis was 
normal. Patient continued to be spikes 
of fever up to 40°C and doxycycline 
100mg twice daily was added for 
possible leptospirosis.  One week later 
his repeated urine analysis revealed 15-
20 WBCs and 30-50 RBCs per high 
power field,2+ protein, 3+ blood,  and 
coarse granular cast, but urine culture 
showed no growth. His creatinine was 
in the range of 1.2-1.7 mg/dl.  Diagnosis 
of leptospirosis was established by 
positive IgM-ELISA titer of 1: 20 (cut-off 
of the assay 9U/ml). Patient was treated 
with penicillin 4 million unit/6 hr 
intravenously. Improvement in 
laboratory and clinical findings 
occurred slowly, and the patient was 
finally discharged after 15 days of 
hospitalization with normal 
hematological and biochemical tests. 
 
Discussion 
 Leptospirosis is a zoonotic disease 
caused by the spirochetes of the genus 
Leptospira (Figure 1). Leptospirosis has 
a worldwide distribution. The incidence 
of human infection is higher in the 
tropics than in temperate regions but 
transmission occurs in both 
industrialized and developing countries. 
Direct exposure to urine of infected 
animals or urine – contaminated water  
 
 
Figure 1: A typical leptospira interrogans 
and soil, through recreational or 
occupational activities represent the 
main source of infection for humans 1. 
Leptospirosis was formerly considered 
to be primarily an occupational disease, 
associated with activities such as 
mining, sewer maintenance, livestock 
farming and butchering, veterinary 
medicine, and military maneuvers2. The 
relative importance of such occupational 
risks has decreased since protective 
measures have been implemented. In 
developed countries, many cases occur 
in association with conditions of slum 
living4 or with recreational activities 
involving immersion in water 5. In 
tropical environments, occupational 
exposure such as rice farming and other 
agricultural activities is still significant 6. 
Leptospirosis was never reported from 
Saudi Arabia possibly because it is a dry 
country or it could be under diagnosed 
due its variable and often nonspecific 
clinical presentation, lack of awareness 
of the disease and relatively inaccessible
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and insufficiently rapid diagnostics.  
Acute fever in patients is a diagnostic 
challenge. This is especially true when 
complications such as hemoptysis, 
jaundice, and thrombocytopenia 
supervene. Other infectious diseases, 
such as malaria, dengue, yellow fever, 
viral hepatitis, and tuberculosis, as well 
as noninfectious disorders, such as small 
vessel vasculitides, could have 
conceivably explained the clinical 
presentations as described7. 
Leptospirosis produces numerous 
clinical findings, but two general 
patterns occur. In the less severe and 
generally nonfatal form, often called 
anicteric leptospirosis and accounting 
for 90% of cases, the illness commonly 
begins abruptly and includes headache, 
myalgias, severe conjuctival suffusion, 
fever, nausea, vomiting, rash, and 
meningitis. Epistaxis or other minor 
bleeding can occur or myocarditis. In 
addition to these features, the more 
severe form of leptospirosis, called 
icteric leptospirosis or Weil disease, 
causes jaundice, renal impairment, and 
major hemorrhagic complications7. 
Pulmonary symptoms occur in both the 
nonicteric and icteric forms, including 
chest pain secondary to myositis or with 
a pleuritic character 8. Cough develops 
in up to 57 to 63% of cases. Many case 
reports, clinical series, and descriptions 
of outbreaks document the frequent 
occurrence of hemoptysis and diffuse 
pulmonary haemorrhage 9, 10. The 
severity of respiratory disease is 
unrelated to the presence of jaundice 11. 
Although much study has been 
dedicated to the serious, sometimes 
dramatic kidney lesions observed in 
severe leptospirosis, such findings are 
not prominent in mild leptospirosis and 
may not be apparent at all in some  
patients with severe forms9. 
Abnormalities can be detected on urine 
analysis in 80% to 90% of patients. In the 
septicaemic phase, red cells, leukocytes, 
or granular casts are found in the urine 
of most patients. Hemoglobinuria and 
hyaline casts also occur. Frequently, 
there is proteinuria and myoglobinuria. 
In hospitalized patients with renal 
failure, they may occur within 3 to 4 
days of onset. Blood urea and creatinine 
levels raise rapidly, with corresponding 
increases in blood potassium, uric acid, 
and phosphate levels. Glomerular 
function and anatomic integrity are 
largely preserved, whereas severe 
proximal tubular lesions do occur 12 . 
Renal failure may or may not be 
prerenal. Oliguria is a striking but rather 
uncommon feature 12. Laboratory 
abnormalities include anemia and  
thrombocytopenia. Myositis may cause 
elevated muscle enzymes. In icteric 
leptospirosis, the serum bilirubin 
typically remains < 20 mg/dL. 
Transaminases are also usually raised to 
two to three times above normal 2 . In 20 
to 40% of icteric cases, renal impairment 
develops, accompanied by elevations in 
BUN (typically < 100 mg/dL) and 
creatinine (usually 2.0 to 8.0 mg/dL), as 
well as proteinuria, hematuria, and 
pyuria 2. Fatalities, significantly more 
frequent in the icteric form, typically 
arise from renal, cardiac, or respiratory 
failure.  
Serology is the most frequently used 
diagnostic approach for leptospirosis. 
The microscopic agglutination test 
(MAT) is the reference standard test for 
serological diagnosis of leptospirosis 
because of its high sensitivity and 
specificity 13, 14. The MAT detects 
agglutinating antibodies in serum, but 
requires significant expertise from its 
users, and interlaboratory variation in  
results is high. Rapid genus-specific 
tests have been used widely for 
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